Alignment Healthcare (ALHC) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended September 2025, Alignment Healthcare (ALHC) reported revenue of $993.7 million, up 43.5% over the same period last year. EPS came in at $0.02, compared to -$0.14 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $980.95 million, representing a surprise of +1.3%. The company delivered an EPS surprise of +128.57%, with the consensus EPS estimate being -$0.07.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Alignment Healthcare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Medical Benefit Ratio: 87.2% versus 88.8% estimated by five analysts on average.Health Plan Membership - Ending: 229,600 versus the four-analyst average estimate of 226,424.Revenues- Other: $10.01 million versus $9.09 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +26.2% change.Revenues- Earned premiums: $983.68 million compared to the $973.54 million average estimate based on three analysts. The reported number represents a change of +43.7% year over year.View all Key Company Metrics for Alignment Healthcare here>>>Shares of Alignment Healthcare have returned +8.3% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Alignment Healthcare, Inc. (ALHC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks